Rapport Therapeutics shares owned by Longwood Capital Partners
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Longwood Capital Partners
from 13F filings
Historical chart of Longwood Capital Partners investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Longwood Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $227k | 20k | 11.37 |
| 2025-03-31 | $165k | 16k | 10.03 |
| 2024-12-31 | $291k | 16k | 17.74 |
| 2024-09-30 | $360k | 18k | 20.48 |
| 2024-06-30 | $465k | 20k | 23.26 |